Business
OXB Launches Advisory Board
OXB Launches Advisory Board.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n\n \n \n \nOXB Highlights the Launch of its Innovation and Technology Excellence Board\nOxford, UK - 03 June 2025: OXB (LSE: OXB) (\"the Company\"), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch of its Innovation and Technology Excellence Board (ITEB). The ITEB brings together leading experts in cell and gene therapy, scientific innovation, and advanced manufacturing. It will advise OXB on technology priorities, innovation opportunities and emerging trends that support the Company's growth as a pure-play CDMO.\n \nThe newly formed advisory board, which held its inaugural meeting last month, will identify opportunities to enhance scientific capabilities to ensure that OXB remains at the forefront of developing innovative technologies. This strategic insight will allow OXB to further enhance its value proposition to clients, while strengthening its market-leading position in the cell and gene therapy space.\n \nDr. Frank Mathias, Chief Executive Officer of OXB, commented: \"The Innovation and Technology Excellence Board marks a key step in OXB's evolution as a pure-play CDMO focused on delivering best-in-class innovation for our clients. By bringing together some of the most respected voices in cell and gene therapy and biomanufacturing, we are creating a structure that will help us stay ahead of scientific and technological change, improve the way we work, and ultimately help our clients bring transformative therapies to patients.\"\n \nProfessor Dame Kay Davies DPhil FRS, Chair of OXB's Innovation and Technology Excellence Board, added: \"Cell and gene therapy continues to evolve quickly, and staying on top of that progress requires both scientific depth and external perspective. ITEB brings together a range of expertise to help OXB focus its innovation where it matters most: improving the way treatments are developed, manufactured and delivered. Our goal is to ensure that innovation leads to practical advances for OXB's clients and better outcomes for patients.\"\n \nFounding members of OXB's Innovation and Technology Excellence Board are:\n \nProf. Dame Kay Davies DPhil FRS (ITEB Committee Chair and Senior Independent Non-Executive Director of OXB) is among the most respected figures in human genetics, known for her research into ...